Back to search
Previous page
NB! Don't use browsers BACK button!


Application data:

Application number: P200200129
Patent number: 05375 
PCT application number: FI00/00761
Filing date of the application: 08.09.2000
Publication date: 15.04.2003
Date of the grant of the patent: 15.02.2011
Priority date: 10.09.1999
Estonian title :    Levosimendani farmatseutiline lahus
English title :    Pharmaceutical solution of levosimendan
Status: Patent protection period expired
Fees paid for the years of validity : 20 
IPC class: A61K31/501
A61K9/08
CPC class:
Estonian abstract: Leiutis puudutab levosimendani lahuste farmatseutilist kasutamist, ja eriti veenisisest manustamist. Leiutisele vastavad lahused on kõrge stabiilsusega ja eriti tõhusad infusiooni- või süstimislahustena või infusioonikontsentraatidena. Levosimendan on tõhus kongestiivse südamerikke ravis.
English abstract: The invention relates to levosimendan solutions for pharmaceutical use, and particularly for intravenous administration. The solutions of the invention have enhanced stability and they are particularly useful as infusion or injection solutions or infusion concentrates. Levosimendan is useful in the treatment of congestive heart failure.
Applicant/holder: Orion Corporation
Inventor name: Reijo  Bäckström (FI)
Päivi  Granvik (FI)
Ritva  Haikala (FI)
Sirpa  Pelttari (FI)
Eva  Saukko (FI)
Reija  Yrjölä (FI)
Drawing(s):
Click on the drawing to display a larger drawing!
Published patent application: Display the published patent application (Document A)
Patent specification: Display patent specification (Document B)
Patent attorney:  
   
Display: DATA OF THE FEES
 
 
Back to search
Previous page